Ondrus, Alison E. and Lee, Hsiao-lu D. and Iwanaga, Shigeki and Parsons, William H. and Andresen, Brian M. and Moerner, W. E. and Du Bois, J. (2012) Fluorescent Saxitoxins for Live Cell Imaging of Single Voltage-Gated Sodium Ion Channels beyond the Optical Diffraction Limit. Chemistry and Biology, 19 (7). pp. 902-912. ISSN 1074-5521. PMCID PMC3731772. doi:10.1016/j.chembiol.2012.05.021. https://resolver.caltech.edu/CaltechAUTHORS:20170901-132021426
![]() |
PDF
- Accepted Version
See Usage Policy. 4MB |
![]() |
PDF (Document S1. Figures S1–S8 and Supplemental Experimental Procedures.)
- Supplemental Material
See Usage Policy. 1MB |
![]() |
Video (MPEG) (Movie S1. Super-Resolution Weighted Moving Average, Related to Figures 5 and S8.)
- Supplemental Material
See Usage Policy. 636kB |
Use this Persistent URL to link to this item: https://resolver.caltech.edu/CaltechAUTHORS:20170901-132021426
Abstract
A desire to better understand the role of voltage-gated sodium channels (NaVs) in signal conduction and their dysregulation in specific disease states motivates the development of high precision tools for their study. Nature has evolved a collection of small molecule agents, including the shellfish poison (+)-saxitoxin, that bind to the extracellular pore of select NaV isoforms. As described in this report, de novo chemical synthesis has enabled the preparation of fluorescently labeled derivatives of (+)-saxitoxin, STX-Cy5, and STX-DCDHF, which display reversible binding to NaVs in live cells. Electrophysiology and confocal fluorescence microscopy studies confirm that these STX-based dyes function as potent and selective NaV labels. The utility of these probes is underscored in single-molecule and super-resolution imaging experiments, which reveal NaV distributions well beyond the optical diffraction limit in subcellular features such as neuritic spines and filopodia.
Item Type: | Article | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Related URLs: |
| |||||||||||||||
ORCID: |
| |||||||||||||||
Additional Information: | Ⓒ 2012 Elsevier Ltd. Received: February 24, 2012. Revised: May 24, 2012. Accepted: May 25, 2012. Published: July 26, 2012. A.E.O., H.L., S.I., B.M.A., W.E.M., and J.D. designed research; A.E.O., H.L., S.I., and W.H.P. performed research; A.E.O., H.L., and S.I. analyzed data; and A.E.O., H.L., W.E.M., and J.D. wrote the paper. The authors thank Professor R.J. Twieg and J.C. Williams for the gift of DCDHF-NHS. We are grateful to Professor Merritt Maduke for allowing use of her electrophysiology equipment and for many helpful discussions. This work was supported in part by R01-GM086196 (to W.E.M.) and R01-NS45684 (to J.D.) from the National Institute of General Medical Sciences and the National Institute of Neurological Disorders and Stroke, respectively, and by a grant from the Tobacco-Related Disease Research Program (to J.D.). W.H.P. is the recipient of a Stanford Interdisciplinary Graduate Fellowship. J.D. is a cofounder of SiteOne Therapeutics, Inc. | |||||||||||||||
Funders: |
| |||||||||||||||
Issue or Number: | 7 | |||||||||||||||
PubMed Central ID: | PMC3731772 | |||||||||||||||
DOI: | 10.1016/j.chembiol.2012.05.021 | |||||||||||||||
Record Number: | CaltechAUTHORS:20170901-132021426 | |||||||||||||||
Persistent URL: | https://resolver.caltech.edu/CaltechAUTHORS:20170901-132021426 | |||||||||||||||
Usage Policy: | No commercial reproduction, distribution, display or performance rights in this work are provided. | |||||||||||||||
ID Code: | 81079 | |||||||||||||||
Collection: | CaltechAUTHORS | |||||||||||||||
Deposited By: | Donna Wrublewski | |||||||||||||||
Deposited On: | 05 Sep 2017 19:21 | |||||||||||||||
Last Modified: | 25 Apr 2022 20:49 |
Repository Staff Only: item control page